MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

172.06 -2.31 (-1.32%)
Official Closing Price Updated: 4:15 PM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,657,738
Open 174.21
Bid (Size) 170.67 (1,500)
Ask (Size) 173.45 (1,400)
Prev. Close 174.37
Today's Range 172.01 - 174.45
52wk Range 107.43 - 179.64
Shares Outstanding N/A
Dividend Yield 0.21%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? ↗
Via Stocktwits
News headline image
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗
The company stated that its product, Symvess, is the only human-derived bioengineered blood vessel approved by the U.S. Food and Drug Administration. 
Via Stocktwits

Performance

YTD
+1.8%
+1.8%
1 Month
+0.4%
+0.4%
3 Month
+4.8%
+4.8%
6 Month
+28.4%
+28.4%
1 Year
+26.4%
+26.4%

More News

Read More
News headline image
Why Is ALVO Stock Rising Pre-Market Today? ↗
Via Stocktwits
News headline image
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
Via MarketMinute
Topics ETFs Government Initial Public Offering
Why IBRX Stock Is One Of The Biggest Pre-Market Movers Today ↗
Via Stocktwits
IBRX Stock Finds Retail Cheer After Company’s Immunotherapy For Bladder Cancer Gets Saudi FDA Approval ↗
Via Stocktwits
Why Did NRXP Stock Surge 21% Pre-Market Today? ↗
Via Stocktwits
IBRX Garners Retail Attention On Positive Update In Immunotherapy For Lung Cancer Patients ↗
Via Stocktwits
News headline image
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock ↗
Via Stocktwits
News headline image
Why Did SER Stock Surge Over 70% In Pre-Market Today? ↗
Via Stocktwits
News headline image
This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF ↗
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
Via The Motley Fool
Topics ETFs Intellectual Property World Trade
Vanda’s FDA Moment: A High-Stakes Bet That Could Redefine The Stock ↗
Via Stocktwits
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
Why NVAX Stock Is Popping Pre-Market – And What Does Pfizer Have To Do With It? ↗
Via Stocktwits
News headline image
Why This Fund Cashed Out of a $3.6 Million Biotech ETF Bet ↗
Via The Motley Fool
Topics ETFs Regulatory Compliance
News headline image
Moderna And Super Micro Top S&P 500 Short Interest List — Are They Ripe For A Squeeze? ↗
Via Stocktwits
Topics Artificial Intelligence Stocks
News headline image
5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗
Via MarketBeat
News headline image
Clean Energy’s Second Wind: What iShares Global Clean Energy ETF Tells Us Now ↗
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals ↗
Via The Motley Fool
Topics ETFs Regulatory Compliance
News headline image
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
Via Benzinga
Topics ETFs
News headline image
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗
Via Benzinga
News headline image
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures ↗
Via Benzinga
News headline image
Enpro Moves To Boost Profits With $280 Million Acquisition Push ↗
Via Benzinga

Frequently Asked Questions

Is iShares Biotechnology ETF publicly traded?
Yes, iShares Biotechnology ETF is publicly traded.
What exchange does iShares Biotechnology ETF trade on?
iShares Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for iShares Biotechnology ETF?
The ticker symbol for iShares Biotechnology ETF is IBB on the Nasdaq Stock Market
What is the current price of iShares Biotechnology ETF?
The current price of iShares Biotechnology ETF is 172.06
When was iShares Biotechnology ETF last traded?
The last trade of iShares Biotechnology ETF was at 02/10/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story